Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 34 entries
View as:

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

Phase: N/A Priority: Normal
NCT ID: NCT02680574 Org: User:
Start: 02/29/16 End: 07/31/20 Due: 07/31/21

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

Phase: N/A Priority: Normal
NCT ID: NCT03054350 Org: User:
Start: 12/31/16 End: 01/24/18 Due: 01/24/19

Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

Phase: N/A Priority: Normal
NCT ID: NCT03242967 Org: User:
Start: 08/31/17 End: 02/12/18 Due: 02/12/19

Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin

Phase: N/A Priority: Normal
NCT ID: NCT03801746 Org: User:
Start: 07/20/18 End: 08/15/18 Due: 08/15/19

Effect of AKB-6548 on Cardiac Repolarization Intervals in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02062203 Org: User:
Start: 01/31/14 End: 04/30/14 Due: 04/30/15

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02260193 Org: User:
Start: 09/10/14 End: 07/22/15 Due: 07/22/16

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05082571 Org: User:
Start: 01/31/25 End: 10/31/26 Due: 10/31/27

Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT03801733 Org: User:
Start: 06/17/18 End: 11/24/18 Due: 11/24/19

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01235936 Org: User:
Start: 10/21/10 End: 05/31/11 Due: 05/31/12

Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548

Phase: N/A Priority: Normal
NCT ID: NCT02327546 Org: User:
Start: 12/31/14 End: 02/28/15 Due: 02/28/16

Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02412449 Org: User:
Start: 04/30/15 End: 04/30/15 Due: 04/30/16

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Phase: N/A Priority: Normal
NCT ID: NCT03140722 Org: User:
Start: 05/02/17 End: 03/21/18 Due: 03/21/19

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Phase: N/A Priority: Normal
NCT ID: NCT03799627 Org: User:
Start: 01/31/19 End: 07/15/20 Due: 07/15/21

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01906489 Org: User:
Start: 07/23/13 End: 09/03/14 Due: 09/03/15

A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03639155 Org: User:
Start: 04/12/18 End: 05/23/18 Due: 05/23/19

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01381094 Org: User:
Start: 06/15/11 End: 02/16/12 Due: 02/16/13

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Phase: N/A Priority: Normal
NCT ID: NCT03054337 Org: User:
Start: 10/31/16 End: 08/28/17 Due: 08/28/18

A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT03799848 Org: User:
Start: 06/12/18 End: 10/18/18 Due: 10/18/19

Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

Phase: N/A Priority: Normal
NCT ID: NCT04299633 Org: User:
Start: 06/15/20 End: 09/28/20 Due: 09/28/21

Effect of AKB-6548 on the Pharmacokinetics of Celecoxib

Phase: N/A Priority: Normal
NCT ID: NCT02502500 Org: User:
Start: 07/31/15 End: 09/30/15 Due: 09/30/16

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Phase: N/A Priority: Normal
NCT ID: NCT03217591 Org: User:
Start: 08/01/17 End: 08/20/19 Due: 08/20/20

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT03992066 Org: User:
Start: 05/28/19 End: 07/15/20 Due: 07/15/21

Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Phase: N/A Priority: Normal
NCT ID: NCT02865850 Org: User:
Start: 07/31/16 End: 03/30/20 Due: 03/30/21

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Phase: N/A Priority: Normal
NCT ID: NCT02892149 Org: User:
Start: 08/31/16 End: 03/30/20 Due: 03/30/21

To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT06901505 Org: User:
Start: 04/30/25 End: 04/30/26 Due: 04/30/27